Actelion Pharmaceuticals Ltd / Actelion statement . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.
ALLSCHWIL, SWITZERLAND - 25 November 2016 - Actelion (SIX: ATLN) confirmed today that it has been approached by Johnson & Johnson about a possible transaction.
There can be no certainty that a transaction will result.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via Globenewswire
--- End of Message ---
Actelion Pharmaceuticals Ltd
Gewerbestrasse 16 Allschwil Switzerland